Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Epinephrine and Somatostatin

supplement:

Epinephrine

Research Papers that Mention the Interaction

In conclusion, somatostatin counteracts the decrease of platelet aggregation response to ADP seen in saline studies, induces the appearance of platelet aggregates in diabetics and potentiates the aggregation response to epinephrine (in vitro) in both normals and diabetics.
In in vitro studies, somatostatin augmented the aggregation response to epinephrine in both normals and diabetics.
Diabete & metabolisme  •  1980  |  View Paper
At both stages of fasting, epinephrine stimulated glucagon, secretion, and this was blocked by somatostatin.
Somatostatin also inhibited this early glycogenolytic response when the epinephrine dose was increased fivefold.
The American journal of physiology  •  1977  |  View Paper
Urinary excretion of norepinephrine, epinephrine , dopamine, PGE2, and PGF2alpha was suppressed under somatostatin.
Klinische Wochenschrift  •  2005  |  View Paper
If adrenaline acts via cyclic AMP as a second messenger it would suggest that adrenaline is safer when given with somatostatin than when given alone.
Anaesthesia  •  1993  |  View Paper
If adrenaline acts via cyclic AMP as a second messenger it would suggest that adrenaline is safer when given with somatostatin than when given alone.
Anaesthesia  •  1993  |  View Paper
The delayed afterdepolarizations or triggered action potentials induced by high-frequency electrical drive in the presence of epinephrine were also suppressed by somatostatin.
Journal of molecular and cellular cardiology  •  1987  |  View Paper
Somatostatin potentiates the venoconstrictive activity of noradrenaline, adrenaline and dopamine, but not that of 5-hydroxytryptamine and tyramine.
Regulatory Peptides  •  1987  |  View Paper
Plasma NEFA levels were raised by somatostatin plus adrenaline (0·55 ± 0·04–1·82 ± 0·11 mmol l‐1 at 60 min).
Somatostatin plus adrenaline and somatostatin plus cortisol resulted in hyperglycaemia (at 240 min, somatostatin plus adrenaline 11·4 ± 0·4 mmol l‐1, P < 0·001; somatostatin plus cortisol 6·7 ± 0·3 mmol l‐1, P < 0·05; somatostatin alone 4·9 ± 0·4 mmol l‐1).
European journal of clinical investigation  •  1986  |  View Paper
Somatostatin suppressed insulin, glucagon and growth hormone secretion and both magnified and prolonged the hyperglycaemic effect of adrenaline (maximal at 105 min, 11.3 +/- 0.5 mmol/l, p less than 0.01 versus adrenaline alone).(ABSTRACT TRUNCATED AT 250 WORDS)
Diabete & metabolisme  •  1984  |  View Paper
During epinephrine plus somatostatin , glucose production still increased transiently, but further suppression of glucose clearance caused more marked hyperglycemia.
The American journal of physiology  •  1979  |  View Paper
Show More